title: Effect of intermittent administration of human parathyroid hormone (1-34) on the mandibular condyle of ovariectomized rats.
abstract: Intermittent administration of human parathyroid hormone (1-34) (PTH) increases bone mass in lumbar vertebrae and long bones of osteoporotic experimental animals. However, whether PTH has the same effect on jaw bones remains unclear. This study determined the effect of intermittent administration of PTH on rat mandibular condyle affected by estrogen deficiency. Fifty 6-month-old rats were either sham operated or ovariectomized, then divided into five groups depending on surgical procedure and hormone administration: sham + vehicle (SV), OVX + vehicle (OV), OVX + PTH 6 micrograms/kg once per week (OP6-1), OVX + PTH 60 micrograms/kg once per week (OP60-1), and OVX + PTH 20 micrograms/kg three times per week (OP20-3). PTH or vehicle was injected intermittently for 6 months in 5 rats of each group either immediately after surgery in a preventive administration experiment, or injected starting 6 months after surgery in a therapeutic administration experiment. The mandibles were excised, and bone morphometry was performed using confocal laser scanning microscopy and soft X-ray images. In both experiments, the bone volume of the OV groups was significantly lower than that of the SV group (P < 0.01); also, depending on dose and frequency, the bone volume of the OP group was higher than that of the OV group, particularly in the OP20-3 group. The value of mineralized surface of the OP groups was significantly higher than that of the OV group (P < 0.01), whereas the value of eroded surface of the OP groups was not significantly higher than that of the OV group. This study indicates that preventive and therapeutic intermittent administration of PTH in ovariectomized rats increase the bone formation in rat mandibular condyle without accelerating bone resorptive activity. This anabolic effect was best induced by the injection mode of 20 micrograms/kg three times per week.
authors.affiliation: Department of Removable Prosthodontics, Niigata University, School of Dentistry, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Nakajima
authors.forename: S
authors.initials: S
authors.lastname: Ejiri
authors.forename: M
authors.initials: M
authors.lastname: Tanaka
authors.forename: E
authors.initials: E
authors.lastname: Toyooka
authors.forename: S
authors.initials: S
authors.lastname: Kohno
authors.forename: H
authors.initials: H
authors.lastname: Ozawa
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D008334:Mandible / Q000033:anatomy & histology / Q000000981:diagnostic imaging / Q000187:drug effects*; D010052:Ovariectomy; D011859:Radiography; D051381:Rats; D011916:Rats, Inbred F344; D019379:Teriparatide / Q000008:administration & dosage*
chemical_list: D019379:Teriparatide